Interferon-induced restriction of Chikungunya virus infection

Antiviral Res. 2023 Feb:210:105487. doi: 10.1016/j.antiviral.2022.105487. Epub 2022 Dec 22.

Abstract

Chikungunya virus (CHIKV) is an enveloped RNA virus that causes Chikungunya fever (CHIKF), which is transmitted to humans through the bite of infected Aedes mosquitos. Although CHIKVF had been regarded as an endemic disease in limited regions of Africa and Asia, the recent global reemergence of CHIKV heightened awareness of this infectious disease, and CHIKV infection is currently considered an increasing threat to public health. However, no specific drug or licensed vaccine is available for CHIKV infection. As seen in other RNA virus infections, CHIKV triggers the interferon (IFN) response that plays a central role in host defense against pathogens. Experimental evidence has demonstrated that control of CHIVK replication by the IFN response is achieved by antiviral effector molecules called interferon-stimulated genes (ISGs), whose expressions are upregulated by IFN stimulation. This review details the molecular basis of the IFN-mediated suppression of CHIKV, particularly the ISGs restricting CHIKV replication.

Keywords: Chikungunya virus; Interferon; Interferon-stimulated genes; Virus restriction.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / metabolism
  • Antiviral Agents / pharmacology
  • Chikungunya Fever*
  • Chikungunya virus* / genetics
  • Humans
  • Interferon Type I*
  • Virus Replication

Substances

  • Antiviral Agents
  • Interferon Type I